openPR Logo
Press release

Cancer Therapeutics Market Key Players| AbbVie Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma Inc., Pfizer Inc., Novartis AG, Merck KGaA

09-18-2019 12:57 PM CET | Health & Medicine

Press release from: KD Market Insights

Cancer Therapeutics Market Key Players| AbbVie Inc., Johnson &

KD Market Insights offers a latest published report on Cancer Therapeutics Market which is expected to grow at a CAGR (Compound Annual Growth Rate) of 7.7% between 2019–2026. In terms of value, the market that is worth the $98,900 million in 2018 and is anticipated to be worth the $180,193 million by 2026. Upsurge in collaboration between pharmaceutical companies, rise in cancer awareness & availability of oncology drugs, increase in cancer funding & research, and growth in geriatric population are the key factors that augment the growth of the cancer therapeutics market. Furthermore, rise in prevalence of cancer cases is expected to boost the market growth.

However, adverse effects associated with cancer therapeutics market and high costs associated with oncology drug development are some of the factors that impede the market growth. Conversely, the high potential of emerging economies and increase in demand for personalized medicine is expected to provide new opportunities for the market players in future.

Request for Sample @ https://www.kdmarketinsights.com/sample/3991

The cancer therapeutics market is segmented based on application, top selling drugs, and region. Based on application, the market is divided into blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, cervical cancer, head & neck cancer, glioblastoma, malignant meningioma, mesothelioma, melanoma, and others. By top selling drugs, it is categorized into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative market analysis from 2018 to 2026 to identify the prevailing opportunities along with strategic assessment of the global cancer therapeutics market.
- Cancer therapeutics market size and market estimations are based on a comprehensive analysis of the applications, top selling drugs, and developments in the industry.
- An in-depth analysis based on region assists to understand the regional market and facilitate the strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS-
By Application
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Breast Cancer
- Cervical Cancer
- Head and Neck Cancer
- Glioblastoma
- Malignant Meningioma
- Mesothelioma
- Melanoma
- Others

By Top Selling Drugs
- Revlimid
- Avastin
- Herceptin
- Rituxan
- Opdivo
- Gleevec
- Velcade
- Imbruvica
- Ibrance
- Zytiga
- Alimta
- Xtandi
- Tarceva
- Perjeta
- Temodar
- Others

By Region
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle-East
- Africa

The list of key players operating in this market include:
- F. Hoffmann-La Roche AG
- Bristol-Myers Squibb Company
- AbbVie, Inc.
- Johnson & Johnson
- Celgene Corporation
- Astellas Pharma, Inc.
- Pfizer, Inc.
- Novartis AG
- Merck KGaA
- Eli Lilly and Company
The other players included in the value chain analysis (and not included in the report) include:
- AstraZeneca plc
- Bayer AG
- Takeda Pharmaceutical Company Limited

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/cancer-therapeutics-market-amr

Table of Contents:

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market share analysis, 2018
3.4. Porters five forces analysis
3.5. Clinical trials
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in prevalence of cancer
3.6.1.2. Surge in cancer research
3.6.1.3. Rise in strategic acquisitions & collaborations
3.6.2. Restraints
3.6.2.1. High cost of drug development and threat of failure
3.6.2.2. Adverse effects associated with cancer drug therapy
3.6.3. Opportunities
3.6.3.1. High potential associated with personalized medicines
3.6.3.2. Increase in purchasing power of emerging economies

CHAPTER 4: CANCER THERAPEUTICS MARKET, APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Blood cancer
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Lung cancer
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Breast cancer
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Colorectal cancer
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Prostate cancer
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Cervical cancer
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Head & neck cancer
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Glioblastoma
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. Malignant meningioma
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country
4.11. Mesothelioma
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country
4.12. Melanoma
4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Others
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast, by region
4.13.3. Market analysis, by country

CHAPTER 5: CANCER THERAPEUTICS MARKET, BY TOP SELLING DRUGS
5.1. Overview
5.1.1. Market size and forecast
5.2. Revlimid
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region
5.3. Avastin
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region
5.4. Herceptin
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region
5.5. Rituxan
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region
5.6. Opdivo
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region
5.7. Gleevec
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region
5.8. Velcade
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by region
5.9. Imbruvica
5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by region
5.10. Ibrance
5.10.1. Market size and forecast, by region
5.10.2. Market analysis, by region
5.11. Zytiga
5.11.1. Market size and forecast, by region
5.11.2. Market analysis, by region
5.12. Alimta
5.12.1. Market size and forecast, by region
5.12.2. Market analysis, by region
5.13. Xtandi
5.13.1. Market size and forecast, by region
5.13.2. Market analysis, by region
5.14. Tarceva
5.14.1. Market size and forecast, by region
5.14.2. Market analysis, by region
5.15. Perjeta
5.15.1. Market size and forecast, by region
5.15.2. Market analysis, by region
5.16. Temodar
5.16.1. Market size and forecast, by region
5.16.2. Market analysis, by region
5.17. Other drugs
5.17.1. Market size and forecast, by region
5.17.2. Market analysis, by region

CHAPTER 6: CANCER THERAPEUTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by application
6.2.3. North America market size and forecast, by application
6.2.4. North America market size and forecast, by top selling drugs
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe cancer therapeutics market, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by application
6.3.2.5. Spain
6.3.2.5.1. Spain market size and forecast, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe market size and forecast, by application
6.3.3. Europe market size and forecast, by application
6.3.4. Europe market size and forecast, by top selling drugs
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by application
6.4.2.2. China
6.4.2.2.1. China market size and forecast, by application
6.4.2.3. India
6.4.2.3.1. India market size and forecast, by application
6.4.2.4. Taiwan
6.4.2.4.1. Taiwan market size and forecast, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea market size and forecast, by application
6.4.2.6. Australia
6.4.2.6.1. Australia market size and forecast, by application
6.4.2.7. Rest of Asia-Pacific
6.4.2.7.1. Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by application
6.4.4. Asia-Pacific market size and forecast, by top selling drugs
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.2.1. Latin America
6.5.2.1.1. Latin America market size and forecast, by application
6.5.2.2. Middle East
6.5.2.2.1. Middle East market size and forecast, by application
6.5.2.3. Africa
6.5.2.3.1. Africa market size and forecast, by application
6.5.3. LAMEA market size and forecast, by application
6.5.4. LAMEA market size and forecast, by top selling drugs
Continue….

Check for Discount @ https://www.kdmarketinsights.com/discount/3991

Contact Us:

KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
Read More News: https://marketnewsbizz.com
https://marketresearchtab.com
https://kdmarketinsightsblog.com

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Therapeutics Market Key Players| AbbVie Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma Inc., Pfizer Inc., Novartis AG, Merck KGaA here

News-ID: 1834545 • Views: 558

More Releases from KD Market Insights

Surgical Robotics Market Key Players: Smith & Nephew Plc. (Blue Belt Technologie …
A fresh report titled “Surgical Robotics Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Surgical Robotics Market. The competition analysis is also a major part of the report. Global surgical robotics market was valued at $56,294.9 million
US Next Generation Diabetes Therapy and Drug Delivery market Key Players: Abbott …
A fresh report titled “US Next Generation Diabetes Therapy and Drug Delivery market ” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for US Next Generation Diabetes Therapy and Drug Delivery. The competition analysis is also a major
Africa Large Volume Parenterals (LVP) Market Key Players: Abacus Parenteral Drug …
A fresh report titled “Africa Large Volume Parenterals (LVP) Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Africa Large Volume Parenterals (LVP) Market. The competition analysis is also a major part of the report. The Africa large
3D Medical Imaging Services Market Key Players: GE Company (GE Healthcare), Hita …
A fresh report titled “3D Medical Imaging Services Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for 3D Medical Imaging Services Market. The competition analysis is also a major part of the report. The global 3D medical imaging

All 5 Releases


More Releases for Key

Global Fumaric Acid Market with Key Regions,Key Vendors
The 'Global Fumaric Acid (CAS 110-17-8) Market Outlook 2018-2023' offers detailed coverage of fumaric acid industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading fumaric acid producers to provide exhaustive coverage of the market for fumaric acid. The report segments the market and forecasts its size, by volume and value, on the basis
Roofing Coatings Market Key strategic undertakings of key players 2025
Global Roofing Coatings Market: Snapshot The revival of the global economy from the economic downturn that happened in the last decade is providing an upthrust to several industries worldwide, including construction. The expansion of the global construction industry is one of the primary factors stoking the growth of the global roofing coatings market. The construction sector is progressing at a brisk pace in emerging regions such as Asia Pacific, making these
Global Luxury Bag Market Key Development, Key Opportunities
Qyresearchreports include new market research report Global Luxury Bag Market Research Report 2018 to its huge collection of research reports. The global Luxury Bag market is carefully assessed in this report which holds the primary objective of informing its readers about rewarding business prospects and advancements in the industry. Besides studying lucrative opportunities available in the market, the analysts shed light on value forecasts, market restraints, growth factors, and trends. The
Agrochemicals Market: Overview,Key Trends,Opportunities,Dynamics,and Key players
Agrochemicals are specialty chemical products used particularly in agriculture, horticulture and floriculture. It includes broad range of pesticides, synthetic fertilizers, hormones and other chemical growth agents.There are mainly two basic market segment of agrochemicals namely, fertilizers and pesticides. Fertilizers are further segmented in four categories namely nitrogenious, potassic, phosphatic and others. Different segment of Pesticides includes insecticides, herbicides, bio-pesticides and others. For more information about this Report visit @ https://www.persistencemarketresearch.com/market-research/sustainable-insulation-market.asp Growth in
Bluetooth Key
Global and China Bluetooth Key Market 2016-2021 Market Research Report The report Bluetooth Key offers a detailed impact analysis of the key trends shaping the Industry. The Industry determinants, i.e. drivers, restraints, opportunities, and threats have been covered in the report. The research study delivers a detailed analysis of the consumer trends that are influencing the Industry. The impact analysis of the Industry drivers, restraints, and opportunities is presented in the
Exceptional Key Indicator Analysis
Vienna | Reutlingen, October 23rd, 2013 – At the start of 2012, the experienced mechanical engineering company Manz began a comprehensive SRM project with their solution partners POOL4TOOL in order to improve the performance of their global purchasing organization. The focal point of this project was the implementation of a complex key indicator system. Recurring processes in tactical purchasing were also re-engineered and the Manz Group’s heterogeneous system landscape was